Response to selpercatinib versus prior systemic therapy in patients (pts) with RET fusion+ non-smallcell lung cancer (NSCLC)

Category Systematic review
JournalJournal of Clinical Oncology
Year 2021
This article has no abstract
Epistemonikos ID: d7064955397ff588e1bed95573643aa2efc1c23a
First added on: Feb 13, 2025